Welcome to chemicalbook!
China english Japan Germany India
400-158-6606
18162-48-6872-50-4Methylene ChloridenaphthaleneTHFTitanium Dioxide
Structured search
Inquriy
Try our best to find the right business for you.
Messages
Do not miss inquiry messages Please log in to view all inquiry messages.
head sculpture My chemicalbook

Welcome back!

RFQ
skype
MY Account
Top
ChemicalBook > Product Catalogue >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine

N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine

N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine Structure
  • ₹0
  • Product name: N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine
  • CAS: 91147-43-2
  • MF: C11H11N5
  • MW: 213.24
  • EINECS:
  • MDL Number:MFCD14706699
  • Synonyms:N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine;Brimonidine Impurity A;Brimonidine EP Impurity A (Desbromo Brimonidine);Desbromo Brimonidine;Brimonidine impurity II;6-Quinoxalinamine, N-(4,5-dihydro-1H-imidazol-2-yl)-;N-(Imidazolidin-2-ylidene)quinoxali;Brimonidine tartrate Imp A (Pharmeuropa): N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
Properties Safety Information Description
Manufacturer Product number Product description Packaging Price Updated Buy

Properties

Melting point :>210°C (dec.)
Boiling point :393.9±45.0 °C(Predicted)
Density :1.44±0.1 g/cm3(Predicted)
storage temp. :Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility :DMSO (Slightly, Heated), Methanol (Slightly, Sonicated)
form :Solid
pka :8.36±0.10(Predicted)
color :Yellow

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P264 Wash hands thoroughly after handling.
P264 Wash skin thouroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P271 Use only outdoors or in a well-ventilated area.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P332+P313 IF SKIN irritation occurs: Get medical advice/attention.
P337+P313 IF eye irritation persists: Get medical advice/attention.
P501 Dispose of contents/container to..…

Description

N-(4,5-Dihydro-1H-imidazol-2-yl)-6-quinoxalinamine is an analogue of Brimonidine (B677520), a α2-Adrenoceptor agonist and antiglaucoma agent.

More related product prices

Brimonidine Brimonidine D-tartrate 5-bromo-N-(4,4,5,5-tetradeuterio-1H-imidazol-2-yl)quinoxalin-6-amine BriMonidine-2,3-dione 6-Aminoquinoxaline 5-Bromoquinazolin-6-ylthiourea 5-Bromoquinoxalin-6-amine 134892-46-9

Related product price

Suppliers and manufacturers

OPULENT PHARMA Anant Pharmaceuticals Pvt Ltd SynThink RESEARCH CHEMICALS KARPSCHEM LABORATORIES CLEARSYNTH LABS LTD. Pharmaffiliates Analytics and Synthetics P. Ltd SynZeal Research Pvt Ltd Dhamtec Pharma And Consultants RXN Chemicals Private Limited Anant Pharmaceuticals Pvt. ltd